Cornerstone Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Cornerstone Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$287K	Buy	+70,569	New	+$6.31M	0.22%	75

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Cornerstone Wealth Management's IBB Position: Q1 2016 in Review

Cornerstone Wealth Management opened a new position in iShares Biotechnology ETF (IBB) in Q1 2016: 70,569 shares worth $287K. The stake represents 0.22% of the portfolio and ranks #75 among its holdings.

415 funds tracked by Wall St. Rank hold IBB as of Q1 2016.

Cornerstone Wealth Management held 70,569 shares of iShares Biotechnology ETF worth $287K as of Q1 2016.
iShares Biotechnology ETF was a new Cornerstone Wealth Management position in Q1 2016.
iShares Biotechnology ETF made up 0.22% of Cornerstone Wealth Management's portfolio in Q1 2016, its #75 holding.
415 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2016.

Based on Cornerstone Wealth Management's 13F filing for Q1 2016, filed 16 May 2016.